ME00934B - Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine - Google Patents
Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždineInfo
- Publication number
- ME00934B ME00934B MEP-2009-298A MEP29809A ME00934B ME 00934 B ME00934 B ME 00934B ME P29809 A MEP29809 A ME P29809A ME 00934 B ME00934 B ME 00934B
- Authority
- ME
- Montenegro
- Prior art keywords
- cyclopropylmethoxy
- carboxamide
- dichloro
- pyridine
- methoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Predmetni pronalazak se odnosi na upotrebu 4-ciklopropilmetoksi- N -( 3 , 5-dihloro-1- oksido-piridin-4-il)-5-(metoksi)- piridin-2-karboksamida za dobijanje leka za lečenje trauma kičmene moždine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0702851A FR2915098B1 (fr) | 2007-04-19 | 2007-04-19 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere |
PCT/FR2008/000533 WO2008145840A2 (fr) | 2007-04-19 | 2008-04-16 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere |
Publications (1)
Publication Number | Publication Date |
---|---|
ME00934B true ME00934B (me) | 2012-06-20 |
Family
ID=38779706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2009-298A ME00934B (me) | 2007-04-19 | 2008-04-16 | Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine |
Country Status (33)
Country | Link |
---|---|
US (1) | US8592443B2 (me) |
EP (1) | EP2150253B1 (me) |
JP (1) | JP5386477B2 (me) |
KR (1) | KR101470043B1 (me) |
CN (1) | CN101674829B (me) |
AR (1) | AR066106A1 (me) |
AT (1) | ATE503481T1 (me) |
AU (1) | AU2008257321B2 (me) |
BR (1) | BRPI0810446A2 (me) |
CA (1) | CA2684172C (me) |
CL (1) | CL2008001134A1 (me) |
CY (1) | CY1111779T1 (me) |
DE (1) | DE602008005873D1 (me) |
DK (1) | DK2150253T3 (me) |
EA (1) | EA015355B1 (me) |
ES (1) | ES2363056T3 (me) |
FR (1) | FR2915098B1 (me) |
HK (1) | HK1142000A1 (me) |
HR (1) | HRP20110459T1 (me) |
IL (1) | IL201451A (me) |
JO (1) | JO2662B1 (me) |
MA (1) | MA31369B1 (me) |
ME (1) | ME00934B (me) |
MX (1) | MX2009011285A (me) |
MY (1) | MY146657A (me) |
NZ (1) | NZ580483A (me) |
PA (1) | PA8776601A1 (me) |
PL (1) | PL2150253T3 (me) |
PT (1) | PT2150253E (me) |
SI (1) | SI2150253T1 (me) |
TW (1) | TWI411435B (me) |
UY (1) | UY31033A1 (me) |
WO (1) | WO2008145840A2 (me) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2915099B1 (fr) | 2007-04-19 | 2009-06-05 | Sanofi Aventis Sa | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens |
SG11201503765XA (en) * | 2012-11-28 | 2015-06-29 | Sanofi Sa | METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF |
AU2013351145A1 (en) * | 2012-11-28 | 2015-06-11 | Sanofi | Process for preparing 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide |
US20220226302A1 (en) | 2021-01-20 | 2022-07-21 | Altos Neuroscience, Inc. | Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditions |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4193926A (en) | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
ES2176251T3 (es) | 1993-07-28 | 2002-12-01 | Aventis Pharma Ltd | Compuestos utilizados como inhibidores de pde iv y del factor de necrosis tumoral(tnf). |
GB9401460D0 (en) | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
GB9507297D0 (en) | 1995-04-07 | 1995-05-31 | Rh Ne Poulenc Rorer Limited | New composition of matter |
US6196968B1 (en) | 1997-06-02 | 2001-03-06 | General Surgical Innovations, Inc. | Direct vision subcutaneous tissue retractor and method for use |
US6177077B1 (en) * | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
JP2003519139A (ja) * | 1999-12-23 | 2003-06-17 | アイコス コーポレイション | 環状amp−特異的ホスホジエステラーゼ阻害剤 |
US20030069169A1 (en) | 2001-03-02 | 2003-04-10 | Macor John E. | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
CA2490097A1 (en) | 2002-07-02 | 2004-01-15 | Merck Frosst Canada & Co. | Di-aryl-substituted-ethane pyridone pde4 inhibitors |
WO2004067006A1 (en) | 2003-01-27 | 2004-08-12 | Pharmacia Corporation | Combination of a pde iv inhibitor and a tnf-alpha antagonist |
BRPI0415167A (pt) * | 2003-10-07 | 2006-11-28 | Renovis Inc | composto de amina como ligandos de canal de ìon e usos dos mesmos |
AU2006257863A1 (en) * | 2005-06-10 | 2006-12-21 | F. Hoffmann-La Roche Ag | Trisubstituted amines as phosphodiesterase 4 inhibitors |
US20070021451A1 (en) * | 2005-07-20 | 2007-01-25 | Hamamatsu University School Of Medicine | Method for preventing or treating neurologic damage after spinal cord injury |
-
2007
- 2007-04-19 FR FR0702851A patent/FR2915098B1/fr not_active Expired - Fee Related
-
2008
- 2008-04-15 PA PA20088776601A patent/PA8776601A1/es unknown
- 2008-04-16 EP EP08787962A patent/EP2150253B1/fr active Active
- 2008-04-16 CA CA2684172A patent/CA2684172C/fr not_active Expired - Fee Related
- 2008-04-16 DE DE602008005873T patent/DE602008005873D1/de active Active
- 2008-04-16 MY MYPI20094338A patent/MY146657A/en unknown
- 2008-04-16 ME MEP-2009-298A patent/ME00934B/me unknown
- 2008-04-16 NZ NZ580483A patent/NZ580483A/en not_active IP Right Cessation
- 2008-04-16 JP JP2010503548A patent/JP5386477B2/ja not_active Expired - Fee Related
- 2008-04-16 BR BRPI0810446-8A2A patent/BRPI0810446A2/pt not_active IP Right Cessation
- 2008-04-16 AT AT08787962T patent/ATE503481T1/de active
- 2008-04-16 DK DK08787962.3T patent/DK2150253T3/da active
- 2008-04-16 AU AU2008257321A patent/AU2008257321B2/en not_active Ceased
- 2008-04-16 CN CN2008800125419A patent/CN101674829B/zh not_active Expired - Fee Related
- 2008-04-16 MX MX2009011285A patent/MX2009011285A/es active IP Right Grant
- 2008-04-16 SI SI200830270T patent/SI2150253T1/sl unknown
- 2008-04-16 KR KR1020097021624A patent/KR101470043B1/ko not_active IP Right Cessation
- 2008-04-16 WO PCT/FR2008/000533 patent/WO2008145840A2/fr active Application Filing
- 2008-04-16 ES ES08787962T patent/ES2363056T3/es active Active
- 2008-04-16 EA EA200970969A patent/EA015355B1/ru not_active IP Right Cessation
- 2008-04-16 PT PT08787962T patent/PT2150253E/pt unknown
- 2008-04-16 PL PL08787962T patent/PL2150253T3/pl unknown
- 2008-04-17 JO JO2008185A patent/JO2662B1/en active
- 2008-04-17 TW TW097114000A patent/TWI411435B/zh not_active IP Right Cessation
- 2008-04-18 AR ARP080101600A patent/AR066106A1/es unknown
- 2008-04-18 CL CL2008001134A patent/CL2008001134A1/es unknown
- 2008-04-18 UY UY31033A patent/UY31033A1/es not_active Application Discontinuation
-
2009
- 2009-10-05 US US12/573,316 patent/US8592443B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201451A patent/IL201451A/en not_active IP Right Cessation
- 2009-11-10 MA MA32335A patent/MA31369B1/fr unknown
-
2010
- 2010-09-10 HK HK10108583.4A patent/HK1142000A1/xx not_active IP Right Cessation
-
2011
- 2011-06-17 HR HR20110459T patent/HRP20110459T1/hr unknown
- 2011-06-28 CY CY20111100611T patent/CY1111779T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012066A (es) | Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k. | |
UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
MX2012007098A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
MX2012007161A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. | |
EA200970913A1 (ru) | 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов | |
WO2009016410A3 (en) | Chemical compounds 831 | |
MX2009004623A (es) | Imidazopiridazinas como inhibidores de la lipido cinasa pi3k. | |
MX2010013682A (es) | Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos. | |
AU2007249926A8 (en) | Monocyclic heteroaryl compounds | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
MX2012007896A (es) | Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica. | |
MX2009006325A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
ME00934B (me) | Upotreba 4-ciklopropilmetoksi-n-(3,5-dtiilor0-1-oksido-piridin-4-il)-5-(metoksi)-piridin-2-karboksamida za liječenje trauma kičmene moždine | |
MX2010002007A (es) | Sulfonas ciclicas sustituidas por amino-bencilo utiles como inhibidores de bace. | |
TW200800993A (en) | Organic compounds | |
GB0609897D0 (en) | Compounds | |
TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
WO2009027736A3 (en) | 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer | |
EA200801678A1 (ru) | Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом | |
ME00935B (me) | Upotreba 4-ciklopropilmetoksi-<i>n</i>-(3,5-dihlor0-1- 0ksido- piridin-4-il)-5-(metoksi)piridin-2- karboksamida za liječenje motoričkih poremećaja povezanih sa parkinsonovom bolešću | |
MX2009012683A (es) | Benzamidas utiles como moduladores del receptor s1p. | |
MX2011011180A (es) | Compuestos que tienen efecto fisiologico. | |
MX2012007097A (es) | Derivados fenolicos y su uso farmaceutico o cosmetico. |